{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:49Z","timestamp":1793237689468,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacadv.2026.103016","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:10:00Z","timestamp":1784765400000},"page":"103016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paroxysmal Supraventricular Tachycardia Treatment"],"prefix":"10.1016","volume":"5","author":[{"given":"Todd C.","family":"Villines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Lacharite-Roberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Rafii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Blood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.103016_bib1","first-page":"e471","volume":"133","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103016_bib2","first-page":"942","article-title":"Common types of supraventricular tachycardia: diagnosis and management","volume":"82","author":"Colucci","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jacadv.2026.103016_bib3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/01.CIR.0000059743.36226.E8","article-title":"Contemporary management of paroxysmal supraventricular tachycardia","volume":"107","author":"Ferguson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103016_bib4","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/jce.15109","article-title":"Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in the United States","volume":"32","author":"Rehorn","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib5","article-title":"Healthcare Resource Utilization (HRU) among patients with paroxysmal supraventricular tachycardia (PSVT)","author":"Desai","year":"2024","journal-title":"AMCP Nexus"},{"key":"10.1016\/j.jacadv.2026.103016_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.010915","article-title":"First randomized, multicenter, placebo-controlled study of self-administered intranasal etripamil for acute conversion of spontaneous paroxysmal supraventricular tachycardia (NODE-301)","volume":"15","author":"Stambler","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejcnurse.2007.02.006","article-title":"Supraventricular tachycardia and the struggle to be believed","volume":"6","author":"Wood","year":"2007","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.jacadv.2026.103016_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archinte.1997.00440260085013","article-title":"Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder","volume":"157","author":"Lessmeier","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacadv.2026.103016_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ahj.2020.12.012","article-title":"Trends in health care resource use and expenditures in patients with newly diagnosed paroxysmal supraventricular tachycardia in the United States","volume":"233","author":"Chew","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacadv.2026.103016_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.amjcard.2019.10.015","article-title":"Healthcare resource use and expenditures in patients newly diagnosed with paroxysmal supraventricular tachycardia","volume":"125","author":"Sacks","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008759","article-title":"Contemporary burden and correlates of symptomatic paroxysmal supraventricular tachycardia","volume":"7","author":"Go","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2026.103016_bib15","article-title":"Emergency department visits in the United States for paroxysmal supraventricular tachycardia are increasing among adults: an analysis from the nationwide emergency department sample","volume":"7","author":"Desai","year":"2026","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"10.1016\/j.jacadv.2026.103016_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103016_bib21","article-title":"Comparison of various vagal maneuvers for supraventricular tachycardia by network meta-analysis","volume":"8","author":"Huang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jacadv.2026.103016_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0196-0644(98)70277-X","article-title":"Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage","volume":"31","author":"Lim","year":"1998","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacadv.2026.103016_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0002-9149(80)90517-2","article-title":"Vagal techniques for termination of paroxysmal supraventricular tachycardia","volume":"46","author":"Waxman","year":"1980","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib24","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(15)61485-4","article-title":"Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial","volume":"386","author":"Appelboam","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2026.103016_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jemermed.2019.06.008","article-title":"Initial and sustained response effects of 3 vagal maneuvers in supraventricular tachycardia: a randomized, clinical trial","volume":"57","author":"Ceylan","year":"2019","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jacadv.2026.103016_bib26","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/01.CIR.98.24.2716","article-title":"Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia","volume":"98","author":"Wen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103016_bib27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jacc.2018.04.082","article-title":"Etripamil nasal spray for rapid conversion of supraventricular tachycardia to sinus rhythm","volume":"72","author":"Stambler","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0140-6736(23)00776-6","article-title":"Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial","volume":"402","author":"Stambler","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacadv.2026.103016_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-113-2-104","article-title":"Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study group","volume":"113","author":"DiMarco","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacadv.2026.103016_bib30","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1097\/CCM.0b013e3181a93661","article-title":"Adenosine for wide-complex tachycardia: efficacy and safety","volume":"37","author":"Marill","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacadv.2026.103016_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0196-0644(05)80829-7","article-title":"Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia","volume":"20","author":"Cairns","year":"1991","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacadv.2026.103016_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0196-0644(94)70128-8","article-title":"Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia","volume":"24","author":"Gausche","year":"1994","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacadv.2026.103016_bib48","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0196-0644(95)70179-6","article-title":"A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting","volume":"25","author":"Madsen","year":"1995","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacadv.2026.103016_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0002-9149(92)90196-6","article-title":"Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study group","volume":"70","author":"Dougherty","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1378\/chest.81.3.267","article-title":"Verapamil for treatment of supraventricular tachyarrhythmias","volume":"81","author":"Waxman","year":"1982","journal-title":"Chest"},{"key":"10.1016\/j.jacadv.2026.103016_bib49","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/j.1552-4604.1988.tb03209.x","article-title":"Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents","volume":"28","author":"Das","year":"1988","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jacadv.2026.103016_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.CIR.71.1.104","article-title":"Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol","volume":"71","author":"Yeh","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2026.103016_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0735-1097(00)01128-1","article-title":"Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia","volume":"37","author":"Alboni","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib19","series-title":"CARDAMYST (etripamil) nasal spray, PRESCRIBING INFORMATION","year":"2025"},{"key":"10.1016\/j.jacadv.2026.103016_bib31","first-page":"CD005154","article-title":"Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia","volume":"10","author":"Alabed","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacadv.2026.103016_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/oxfordjournals.eurheartj.a060553","article-title":"Adenosine for the management of patients with tachycardias--a new protocol","volume":"15","author":"Domanovits","year":"1994","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103016_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.15420\/aer.2019.05","article-title":"Unmasking adenosine: the purinergic signalling molecule critical to arrhythmia pathophysiology and management","volume":"8","author":"Matthews","year":"2020","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.jacadv.2026.103016_bib38","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0002-9149(02)02285-3","article-title":"Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy)","volume":"89","author":"Goldberg","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-8703(86)90471-0","article-title":"Effective termination of reentrant supraventricular tachycardia by single dose oral combination therapy with pindolol and verapamil","volume":"112","author":"Rose","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacadv.2026.103016_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0002-8703(87)90500-X","article-title":"Failure of episodic high-dose oral verapamil therapy to convert supraventricular tachycardia: a study of plasma verapamil levels and gastric motility","volume":"114","author":"Hamer","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacadv.2026.103016_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/cpdd.1383","article-title":"Pharmacokinetics and pharmacodynamics of etripamil, an intranasally administered, fast-acting, nondihydropyridine calcium channel blocker","volume":"13","author":"Ip","year":"2024","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.jacadv.2026.103016_bib41","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1111\/jce.70086","article-title":"Etripamil nasal spray for recurrent paroxysmal supraventricular tachycardia conversion: results from the NODE-303 open-label study","volume":"36","author":"Ip","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028227","article-title":"Etripamil nasal spray for conversion of repeated spontaneous episodes of paroxysmal supraventricular tachycardia during long-term follow-up: results from the NODE-302 study","volume":"12","author":"Ip","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2026.103016_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.123.011681","article-title":"Self-administered etripamil nasal spray relieved symptoms, decreased heart rate, and reduced medical interventions during atrioventricular nodal-dependent paroxysmal supraventricular tachycardia","volume":"17","author":"Stambler","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib44","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.hrthm.2026.01.016","article-title":"A review of etripamil: a new paradigm for treating paroxysmal supraventricular tachycardia for an informed, shared decision","volume":"23","author":"Ip","year":"2026","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacadv.2026.103016_bib45","article-title":"Minimal blood pressure effects of intranasal etripamil for paroxysmal supraventricular tachycardia","volume":"2026","author":"Ip","year":"2026","journal-title":"JACC Adv"},{"key":"10.1016\/j.jacadv.2026.103016_bib46","first-page":"1212","article-title":"Self-administered etripamil nasal spray rapidly terminated spontaneous paroxysmal supraventricular tachycardia (PSVT): analysis of open-label treatment in the RAPID study","volume":"23","author":"Ip","year":"2026","journal-title":"HRS"},{"key":"10.1016\/j.jacadv.2026.103016_bib47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jamacardio.2025.0417","article-title":"Self-administered etripamil and emergency department visits in supraventricular tachycardia: a secondary analysis of a randomized clinical trial","volume":"10","author":"Pokorney","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2026.103016_bib50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.annemergmed.2025.06.623","article-title":"Evaluation of out-of-hospital use of a valsalva assist device in the emergency treatment of supraventricular tachycardia","volume":"86","author":"Appelboam","year":"2025","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacadv.2026.103016_bib51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40814-020-00616-y","article-title":"collaborators EsS. Evaluation of pre-hospital use of a valsalva assist device in the emergency treatment of supraventricular tachycardia [EVADE]: a randomised controlled feasibility trial","volume":"6","author":"Appelboam","year":"2020","journal-title":"Pilot Feasibility Stud"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:27:18Z","timestamp":1793237238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26004370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2772963X26004370"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103016","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paroxysmal Supraventricular Tachycardia Treatment","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103016"}}